SLS (SLS) Stock Price & Analysis
SLS (SLS) rose 1.17% to USD 13.86 as of September 8, 2026 at 07:00 UTC, according to Nexqual real-time market data.
SLS last closed at USD 13.86; the session ranged USD 13.43–14.14 on volume of 4,526,880 shares. Market capitalization is —, with a 52-week range of USD 1.39–15.88 (NCM). Source: Nexqual, September 8, 2026 at 07:00 UTC.
Key Statistics (as of September 8, 2026 at 07:00 UTC)
| Price | USD 13.86 |
|---|---|
| Change | ▲ 1.17% (up) |
| Previous Close | USD 13.86 |
| Open | USD 13.86 |
| Day Range | USD 13.43 – 14.14 |
| 52-Week Range | USD 1.39 – 15.88 |
| Volume | 4,526,880 shares |
| Market Cap | — |
| Exchange | NCM |
Technical Analysis (SLS)
Nexqual's technical model rates SLS "STRONG BUY" based on 5 bullish and 0 bearish signals across 128 daily candles, as of September 8, 2026 at 07:00 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 52.65 (neutral) |
| vs SMA50 | Above (USD 12.8) |
| MACD | 0.53 (positive) |
From SLS's Latest SEC 10-K Filing (filed 2026-03-19)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| GLSI | Greenwich LifeSciences, Inc. | USD 15.95 | ▲ 1.33% |
| IMMP | Immutep Limited | USD 0.36 | ▼ 3.97% |
| VTVT | vTv Therapeutics Inc. | USD 33.35 | ▼ 0.15% |
| IBRX | ImmunityBio, Inc. | USD 8.08 | ▲ 1.64% |
| CAPR | Capricor Therapeutics, Inc. | USD 9.4 | ▼ 4.95% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 07:00 UTC. This page is informational and not investment advice.